Lupin has announced Dr. Ranjana Pathak as its new Chief Quality Officer, succeeding Johnny Mikell. With a robust background spanning over three decades in the industry, Dr. Pathak will oversee quality and regulatory compliance across Lupin’s global operations. Bringing an extensive array of leadership skills to the table, Dr. Pathak’s appointment is poised to enhance Lupin’s commitment to excellence.

Previously, Dr. Pathak has made significant contributions at Dr. Reddy’s as the Global Head for Quality and Pharmacovigilance, and has held key positions in quality and compliance at notable companies like Watson/Actavis and Endo Pharmaceuticals in the US, as well as serving as President and Global Head of Quality, Medical Affairs, and Pharmacovigilance at Cipla. Dr. Pathak’s expertise spans a broad spectrum of pharmaceutical products, including injectables, inhalation items, and biologics, emphasizing both brand-name and generic drugs.

Vinita Gupta, CEO, and Nilesh Gupta, MD of Lupin, expressed their appreciation for Johnny Mikell’s contributions over his tenure and welcomed Dr. Pathak to their leadership team. Dr. Pathak’s extensive global experience and her formidable track record in fostering a culture of quality and compliance are in line with Lupin’s vision of delivering top-notch quality products to the markets it serves.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!